Business

Commentary: ESG investors shouldn’t ignore biotech’s potential to deliver change

Published

2 years ago

on

2 May 2022

By

Terry Power

ESG investors shouldn’t ignore biotech’s potential to deliver change | Fortune

You need to enable JavaScript to view this site.

Related Topics:biotech biotech innovations biotech startups biotechs change Commentary Deliver esg esg investing esg news food prices ignore inflation investors pandemic pollution climate change Potential science shouldnt when will the pandemic end world hunger